CMA helps extend Aspen’s EU commitments to UK following Brexit
Shutterstock/marketolog
Aspen has agreed that price reductions it offered the European Commission in 2019 to end an excessive pricing probe into certain cancer treatments should also apply to the UK’s National Health Service following the country’s exit from the EU.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now